These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30021495)

  • 1. University of Pennsylvania 10th annual conference on statistical issues in clinical trials: Current issues regarding data and safety monitoring committees in clinical trials (morning panel session).
    Davis B; Kerr D; Maguire M; Sanders C; Snapinn S; Wittes J
    Clin Trials; 2018 Aug; 15(4):335-351. PubMed ID: 30021495
    [No Abstract]   [Full Text] [Related]  

  • 2. University of Pennsylvania 10th annual conference on statistical issues in clinical trials: Current issues regarding data and safety monitoring committees in clinical trials (afternoon panel session).
    Dickersin K; Dixon D; Ferris F; Goldberg J; Kimmel S; Lachin J
    Clin Trials; 2018 Aug; 15(4):366-385. PubMed ID: 30021497
    [No Abstract]   [Full Text] [Related]  

  • 3. Proceedings of the University of Pennsylvania 10th annual conference on statistical issues in clinical trials: Current issues regarding Data and Safety Monitoring Committees in clinical trials.
    Ellenberg SS; Ellenberg JH
    Clin Trials; 2018 Aug; 15(4):319-320. PubMed ID: 29932002
    [No Abstract]   [Full Text] [Related]  

  • 4. Data Monitoring Committees: Current issues.
    Fleming TR; Ellenberg SS; DeMets DL
    Clin Trials; 2018 Aug; 15(4):321-328. PubMed ID: 29629815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. When should data and safety monitoring committees share interim results in cardiovascular trials?
    Borer JS; Gordon DJ; Geller NL
    JAMA; 2008 Apr; 299(14):1710-2. PubMed ID: 18398083
    [No Abstract]   [Full Text] [Related]  

  • 6. University of Pennsylvania 7th annual conference on statistical issues in clinical trials: Current issues regarding the use of biomarkers and surrogate endpoints in clinical trials (morning panel discussion).
    Daniels M; Frangakis C; Charu V; Ghosh D
    Clin Trials; 2015 Aug; 12(4):323-32. PubMed ID: 26062596
    [No Abstract]   [Full Text] [Related]  

  • 7. University of Pennsylvania 11th annual conference on statistical issues in clinical trials: Estimands, missing data and sensitivity analysis (morning panel session).
    Rockhold FW; Lindblad A; Siegel JP; Molenberghs G
    Clin Trials; 2019 Aug; 16(4):350-362. PubMed ID: 31303021
    [No Abstract]   [Full Text] [Related]  

  • 8. A major trial needs three statisticians: why, how and who?
    Pocock SJ
    Stat Med; 2004 May; 23(10):1535-9. PubMed ID: 15122734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. University of Pennsylvania ninth annual conference on statistical issues in clinical trials: Where are we with adaptive clinical trial designs? (morning panel discussion).
    Chappell R; Durkalski V; Joffe S
    Clin Trials; 2017 Oct; 14(5):441-450. PubMed ID: 28825324
    [No Abstract]   [Full Text] [Related]  

  • 10. Pursuit of truly independent data monitoring committees in research.
    Marston L; McKenzie DR; Freemantle N
    BMJ; 2016 May; 353():i2309. PubMed ID: 27172924
    [No Abstract]   [Full Text] [Related]  

  • 11. University of Pennsylvania 7th annual conference on statistical issues in clinical trials: Current issues regarding the use of biomarkers and surrogate endpoints in clinical trials (afternoon panel discussion session).
    Hung HM; Inoue L; Pickering E
    Clin Trials; 2015 Aug; 12(4):365-73. PubMed ID: 26178573
    [No Abstract]   [Full Text] [Related]  

  • 12. Monitoring clinical trials: issues and controversies regarding confidentiality.
    Fleming TR; Ellenberg S; DeMets DL
    Stat Med; 2002 Oct; 21(19):2843-51. PubMed ID: 12325100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommendations for data monitoring committees from the Clinical Trials Transformation Initiative.
    Calis KA; Archdeacon P; Bain R; DeMets D; Donohue M; Elzarrad MK; Forrest A; McEachern J; Pencina MJ; Perlmutter J; Lewis RJ
    Clin Trials; 2017 Aug; 14(4):342-348. PubMed ID: 28503947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. University of Pennsylvania 5th annual conference on statistical issues in clinical trials: emerging statistical issues in biomarker validation (Morning Session).
    DeMets D; Wittes J; Siegel J
    Clin Trials; 2013 Oct; 10(5):680-9. PubMed ID: 24130200
    [No Abstract]   [Full Text] [Related]  

  • 15. Data and safety monitoring boards: academic credit where credit is due?
    Armstrong PW; Califf RM
    JAMA; 2013 Oct; 310(15):1563-4. PubMed ID: 24129461
    [No Abstract]   [Full Text] [Related]  

  • 16. Exploring the role and function of trial steering committees: results of an expert panel meeting.
    Harman NL; Conroy EJ; Lewis SC; Murray G; Norrie J; Sydes MR; Lane JA; Altman DG; Baigent C; Bliss JM; Campbell MK; Elbourne D; Evans S; Sandercock P; Gamble C
    Trials; 2015 Dec; 16():597. PubMed ID: 26715378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 14th Annual University of Pennsylvania Conference on statistical issues in clinical trials/subgroup analysis in clinical trials: Opportunities and challenges (morning panel discussion).
    Roes K; Wittes J
    Clin Trials; 2023 Aug; 20(4):351-361. PubMed ID: 37329159
    [No Abstract]   [Full Text] [Related]  

  • 18. Independence of the statistician who analyses unblinded data.
    Siegel JP; O'Neill RT; Temple R; Campbell G; Foulkes MA
    Stat Med; 2004 May; 23(10):1527-9. PubMed ID: 15122732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Data monitoring committees for pragmatic clinical trials.
    Ellenberg SS; Culbertson R; Gillen DL; Goodman S; Schrandt S; Zirkle M
    Clin Trials; 2015 Oct; 12(5):530-6. PubMed ID: 26374679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research review boards dogged by criticism.
    Ledford H
    Nature; 2009 Apr; 458(7238):557. PubMed ID: 19340042
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.